We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
The meeting of the Advisory Committee on Vaccines (ACV).
The committee provided advice on one application:
- provisional registration of a new vaccine for active immunisation for COVID-19 (product name Nuvaxovid; active ingredient SARS-CoV-2 rS with Matrix-M adjuvant; applicant Biocelect Pty Ltd) that had been under evaluation from February 2021.
Members
Membership comprises professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.